PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, Penn State College of Medicine, Hershey, USA. Electronic address: ltchelebi@pennstatehealth.psu.edu.\', \'Department of Radiation Oncology, Particle Therapy Interuniversity Center Leuven, Belgium.\', \'Humanitas Clinical and Research Center - IRCCS, Department of Radiotherapy and Radiosurgery, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.\', \'Department of Radiation Oncology, University of Toronto, Radiation Medicine Program, Princess Margaret Cancer Center, Toronto, Canada.\', \'Department of Radiation Oncology, Hôpital Tenon, AP-HP.Sorbonne Université, Paris, France.\', \'Medical Physics and Biomedical Engineering, University College London, University College London Hospitals NHS Foundation Trust, London, UK.\', \'Department of Biomedical Sciences, Humanitas University, Milan, Italy.\', \'Department of Radiation Oncology, The Mount Sinai Hospital, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0167-8140(20)30191-210.1016/j.radonc.2020.04.010
?:doi
?:hasPublicationType
?:journal
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
is ?:pmid of
?:pmid
?:pmid
  • 32342878
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all